Drug class in one race
IL-13 drugs for Atopic Dermatitis
3 tracked IL-13 drugs in the Atopic Dermatitis race. The class explanation lives on the IL-13 page; the full indication pipeline across every mechanism is on the Atopic Dermatitis page.
2 approved / phase 41 Phase 2
Head-to-head evidence: lebrikizumab vs Zumilokibart · tralokinumab vs Zumilokibart · lebrikizumab vs tralokinumab